Skip to main content
OpenTrials
Completed

NCT Number: NCT03551301

Transitional Case Management for Patients Suffering From Substance Use Disorders

According to the World Health Organization the population suffering from addiction problems is increasing. This population is characterized by multiple needs at the medico-psychosocial level. However, some of these patients, a particular subgroup that we are going to be interested in the so-called "high need" user group, find it difficult to access and stay in outpatient treatment programs. They often present a chaotic use of the health system, including a high number of hospitalizations in times of crisis. They also show very low utilization of health care services, accompanied by social marginalization. This can be related to relapses and poor social functioning. A high number of relapses occur particularly at the end of hospitalization. Interventions in the field of addiction, such as Transitional Case Management (TCM) should increase the adherence of these patients to treatment by accompanying them in the sensitive period following hospitalization. One of the objectives of the study is to evaluate the impact of TCM on the number, duration and type of hospitalizations, as well as the number of emergency room visits. The investigators will also measure the duration until the possible future hospitalization, after the TCM. The secondary objectives of this study will be to see the effect of TCM on adherence to outpatient treatment. The investigators will focus on the impact of follow-up on the participant's medico-psycho-social network, substance use and other psychological variables. The investigators will also evaluate his or her psychiatric symptoms and global and social functioning. Life satisfaction and satisfaction with the care received will also be measured. The investigators will compare the population treated by the TCM with the other users of the addiction service who are hospitalized. The study will investigate this through questionnaires at the beginning of care, at one month, three months, six months and 12 months after the start of TCM management.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Substance Use Disorders Chemically-Induced Disorders Mental Disorders Substance-Related Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Service d'addictologie HUG

Geneva, 1202, Switzerland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Substance use disorder
  • Hospitalisation at recruitment
  • Substance Use Disorder according to the DSM-5 and one of the following criteria:
  • No preexisting outpatient follow-up care or regular follow-up care
  • More than three emergency room visits during the last 12 months
  • More than three hospitalizations in psychiatric hospital during the last 12 months
  • More than 40 hospitalization's days during the last 12 months
  • First hospitalization for a SUD

Exclusion criteria

  • Evidence of organic brain disease or learning disability based on the chart review.

Treatment and study plan

Transitional Case Management

Other

TCM program is a type of very flexible community treatment in terms of frequency and intensity of care. This is facilitated by a small case load ratio per health care professional (1:10). The healthcare workers are specialised in SUD treatment. The intervention begins during hospitalisation and lasts around 4 weeks after discharge from the hospital.

The main aim of this intervention is to accompany the patient in the difficult phase of transition between hospital and outpatient care and ensure their adherence to the treatment program. The healthcare workers will explore specific patient needs and ensure that health and social services are better coordinated to fit their needs. Another important aim is to reduce the number of (unplanned) hospitalizations and emergency room visits.

Primary outcomes

  1. Hospital days

    Time frame: at 12 months

    Number of days in hospital

Secondary outcomes

  1. Service use

    Time frame: at 12 months

    Number of hospital admissions

  2. Patient network

    Time frame: 0, 3, 6, 12 months

    Number of persons in network

  3. Time to first readmission to hospital

    Time frame: 0, 1, 3, 6, 12 months

    Number of days to first readmission

  4. Type of admission (planned versus unplanned)

    Time frame: 0, 1, 3, 6, 12 months

    Type of admission (planned versus unplanned) reviewed on patient file

  5. Number of ER visits

    Time frame: 0, 1, 3, 6, 12 months

    Number of ER visits reviewed on patient file

  6. Treatment adherence

    Time frame: 0, 1, 3, 6, 12 months

    percentage of attended outpatient appointments reviewed on patient file

  7. Number or Transitional Case Management interventions

    Time frame: 0, 1, 3, 6, 12 months

    Number or Transitional Case Management interventions

  8. Addictive behaviour

    Time frame: 0, 1, 3, 6, 12 months

    Alcohol, Smoking and Substance Involvement Screening Test (ASSIST. V.3 French)

  9. General psychiatric symptoms

    Time frame: 0, 1, 3, 6, 12 months

    Health of Nation Outcome Scale - French version (HoNOS-F): scores 0 - 52 (higher score = more psychiatric symptoms)

  10. Global functioning

    Time frame: 0, 1, 3, 6, 12 months

    World Health Organization Disability Assessment Schedule (WHODAS)

  11. General life satisfaction

    Time frame: 0, 1, 3, 6, 12 months

    Satisfaction With Life Scale: scores 5 - 35 (higher score = higher life satisfaction)

  12. Advance directives written by the participants

    Time frame: at Baseline

    Advance directives written by the participant (yes - no)

Other outcomes

  1. Patient satisfaction with Transitional Case Management

    Time frame: at 1 month

    Patient satisfaction with Transitional Case Management

  2. Duration and intensity of Transitional Case Management intervention

    Time frame: at 1 month

    Daily contact log (Relevé quotidien des contacts (RQC))

Sponsors and collaborators

Lead sponsor

University Hospital, Geneva

Other

Registry information

Important dates

Study start
2017
Primary completion
2019
Study completion
2020
First posted
Jun 11, 2018
Registry last updated
Mar 20, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.